- Carrero, Juan J;
- Thomas, Fridtjof;
- Nagy, Kristóf;
- Arogundade, Fatiu;
- Avesani, Carla M;
- Chan, Maria;
- Chmielewski, Michal;
- Cordeiro, Antonio C;
- Espinosa-Cuevas, Angeles;
- Fiaccadori, Enrico;
- Guebre-Egziabher, Fitsum;
- Hand, Rosa K;
- Hung, Adriana M;
- Ikizler, Talat A;
- Johansson, Lina R;
- Kalantar-Zadeh, Kamyar;
- Karupaiah, Tilakavati;
- Lindholm, Bengt;
- Marckmann, Peter;
- Mafra, Denise;
- Parekh, Rulan S;
- Park, Jongha;
- Russo, Sharon;
- Saxena, Anita;
- Sezer, Siren;
- Teta, Daniel;
- Wee, Pieter M Ter;
- Verseput, Cecile;
- Wang, Angela YM;
- Xu, Hong;
- Lu, Yimin;
- Molnar, Miklos Z;
- Kovesdy, Csaba P
Objective
To better define the prevalence of protein-energy wasting (PEW) in kidney disease is poorly defined.Methods
We performed a meta-analysis of PEW prevalence from contemporary studies including more than 50 subjects with kidney disease, published during 2000-2014 and reporting on PEW prevalence by subjective global assessment or malnutrition-inflammation score. Data were reviewed throughout different strata: (1) acute kidney injury (AKI), (2) pediatric chronic kidney disease (CKD), (3) nondialyzed CKD 3-5, (4) maintenance dialysis, and (5) subjects undergoing kidney transplantation (Tx). Sample size, period of publication, reporting quality, methods, dialysis technique, country, geographical region, and gross national income were a priori considered factors influencing between-study variability.Results
Two studies including 189 AKI patients reported a PEW prevalence of 60% and 82%. Five studies including 1776 patients with CKD stages 3-5 reported PEW prevalence ranging from 11% to 54%. Finally, 90 studies from 34 countries including 16,434 patients on maintenance dialysis were identified. The 25th-75th percentiles range in PEW prevalence among dialysis studies was 28-54%. Large variation in PEW prevalence across studies remained even when accounting for moderators. Mixed-effects meta-regression identified geographical region as the only significant moderator explaining 23% of the observed data heterogeneity. Finally, two studies including 1067 Tx patients reported a PEW prevalence of 28% and 52%, and no studies recruiting pediatric CKD patients were identified.Conclusion
By providing evidence-based ranges of PEW prevalence, we conclude that PEW is a common phenomenon across the spectrum of AKI and CKD. This, together with the well-documented impact of PEW on patient outcomes, justifies the need for increased medical attention.